Lowering blood homocysteine with folic acid based supplements: Meta-analysis of randomised trials

British Medical Journal

Volumn 316, Issue 7135, 1998, Pages 894-898

  Clarke, R ^k,m   Brattstrom L ^b   Landgren, F ^b   Israelsson, B ^b   Lindgren, A ^b   Hultberg, B ^b   Andersson, A ^b   Cuskelly, G ^c   McNulty, H ^c   Strain, S S ^c   McPartlin, J ^d   Weir, D G ^d   Scott, J M ^d   den Heijer, H ^e   Brouwer, I A ^e   Blom, H J ^e   Bos, G M J ^e   Spaans, A ^e   Rosendaal, F R ^e   Thomas, C M G ^e   Haak, H L ^e   Wijermans, P W ^e   Gerrits, W B J ^e   Naurath, H J ^f   Joosten, E ^f   Riezler, R ^f   Stabler, S P ^f   Allen, R H ^f   Lindenbaum, J ^f   Pietrzik, K ^g   Prinz­Langenohl, R ^g   Dierkes, J ^g   Saltz­man, E ^h   Mason, J B ^h   Jacques, P ^h   Selhub, J ^h   Salem, D ^h   Schaefer, E ^h   Rosenberg, I H ^h   Ubbink, J ⁱ   van der Mere, A ⁱ   Vermack, W J H ⁱ   Delport, R ⁱ   Becker, P J ⁱ   Potgieter, H C ⁱ   Woodside, J V ^j   Yarnell, J W G ^j   McMaster, D ^j   Young, I S ^j   McCrum, E E ^j   Patterson, S S ^j   Gey, K F ^j   Evans, A E ^j   Appleby, P ^k   Harding, P ^k   Sherliker, P ^k   Collins, R ^k,m   Frost, C ^l,m   Leroy, V ^l,m   more..

^a CLINICAL TRIAL SERVICE UNIT   (United Kingdom)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF ULSTER   (United Kingdom)

^d TRINITY COLLEGE DUBLIN   (Ireland)

^e RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^f UNIVERSITY OF LEUVEN   (Belgium)

^g UNIVERSITY OF BONN   (Germany)

^h TUFTS UNIVERSITY   (United States)

ⁱ UNIVERSITY OF PRETORIA   (South Africa)

^j QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^k UNIVERSITY OF OXFORD   (United Kingdom)

^l LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^m NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FOLIC ACID BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; META ANALYSIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK; VASCULAR DISEASE;

EID: 2242477014     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Boushcy CJ, Beresford SA, Omen GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995;274:1049-57.
2. Clarke R, Daly I, Robinson K, Naughten E, Cahalane S, Fowler B, et al. Hyperhomocysteincmia: an independent risk factor for vascular disease. N Engl J Med 1991:324:1149-55.
3. Arnesen E, Refsum H, Bonaa KH, Ucland PM, Forde OH, Nordrehaug JE, et al. Serum total homocysteine and coronary heart disease. Int J Epidemiol 1995:24:704-9.
4. Perry I, Refsum H, Morris RW, Ebrahim S, Ucland PM, Shaper AC. A prospective study of scrum homocysteine concentration and risk of stroke in middle-aged men. Lancet 1995;346:1395-8.
5. Graham IM, Daly LF, Refsum H, Robinson K, Brattström LE, Ueland PM. et al. Plasma homocysteinc as a risk factor for vascular disease. JAMA 1997;277:1775-81.
6. Selliub J. Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993;270:2693-8.
7. Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, et al. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet 1985;37:I-31.
8. 6 and folic acid therapy in young patients with arteriosclerosis and hyperhomocysteineinia. J Vasc Surg 1994:20:933-40.
9. Franken DG, Boers GHJ, Blom HJ, Trijbets FJM Kloppenberg PW. Treatment of mild hyperhomocysteinemia in vascular disease patients. Arterio-sclerosis Thromb 1994;14:165-70.
10. Wilcken DEL, Dudman NPB, Tyrell PA, Robertson MR. Folic acid lowers plasma homocysteine in chronic renal insufficiency: possible implications for the prevention of vascular disease. Metabolism 1988:37:697-701.
11. Brattström I, Israelsson B, Jeppson JU, Hultberg BL. Folic acid - an innocuous means of reducing plasma homocysteinc. Scand J Clin Lab Invest 1988;48:215-21.
12. Arnadottir M, Brattström L, Simonsen O, Thysell H, Hultberg B, Andersson A, el al. The effect of high-dose pyridoxine and folic acid supplementation on serum lipids and plasma homocysteine. Clin Nephrol 1993;40:236-40.
13. Bostom AG, Shemin D, Lapane KL, Hume AL, Yoburn D, Nadeau MR, et al. High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patients. Kidney Int 1996;49:147-52.
14. Chaveau P, Chadefoux-Vekemans B, Coude M, Aupctit J, Kamoun P, Jungers P. Hyperhomocysteinemia in chronic renal failure patients. Reduction of vascular risk factors by folate supplementation. Ir J Med Sci 1995;164:25.
15. 6 and folale reduce homocysteine concentrations in coronary artery disease. Ir J Med Sci 1993;162:197.
16. Landgren F, Israelsson B, Lindgren A, Hultberg B, Andersson A, Brattström L. Plasma homocysteine in acute myocardial infarction: homocysteine-lowering effect of folic acid. J Intern Med 1995;237:381-8.
17. Den Heijer M, Brouwer IA. Bos GMJ. Blom HJ, Spaans AP, Rosendaal FR, et al. Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers. Arteriosclerosis Thromb Vascular Biol (in press).